Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.01% | 90.69 | 1.3% | $838.74m | |
| AMGN | Amgen Inc. | 0.89% | 188.34 | 1.2% | $621.82m | |
| GILD | Gilead Sciences, Inc. | 1.84% | 67.59 | 0.9% | $512.40m | |
| BIIB | Biogen Inc. | 2.51% | 332.87 | 1.3% | $445.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 423.97 | 2.6% | $305.14m | |
| ILMN | Illumina, Inc. | 2.51% | 299.82 | 3.5% | $302.67m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.27% | 188.07 | 1.9% | $269.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.77% | 129.42 | 2.0% | $233.68m | |
| LOXO | Loxo Oncology Inc | -0.03% | 234.66 | 12.7% | $170.39m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.65% | 138.45 | 15.4% | $148.57m | |
| A | Agilent Technologies, Inc. | 1.64% | 78.28 | 1.6% | $133.87m | |
| INCY | Incyte Corporation | 0.88% | 84.15 | 2.5% | $132.72m | |
| EXAS | Exact Sciences Corporation | 0.49% | 88.55 | 25.3% | $128.36m | |
| ARRY | Array BioPharma Inc. | 4.95% | 23.13 | 8.2% | $105.79m | |
| EXEL | Exelixis, Inc. | -0.18% | 22.26 | 6.4% | $97.74m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.